Joint Formulary & PAD

Guideline Profile : Osteoporosis

Committee Recommendations (2)

Users are signposted to use the NICE CKS guidance for the management of osteoporosis, available at https://cks.nice.org.uk/topics/osteoporosis-prevention-of-fragility-fractures/management/management/

The National Osteoporosis Guideline Group UK (NOGG) clinical guidelines are available here-  https://www.nogg.org.uk/sites/nogg/download/NOGG-Guideline-2021-g.pdf

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed an updated Osteoporosis pathway for specialist (high cost) treatments.

 

Guideline Profile

Indication :
Osteoporosis
Keywords :
bisphosphonates, postmenopausal osteoporosis, bone density, abaloparatide, romosozumab, teriparatide
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
4